YoshifumiNakaMD

Adult Cardiac Surgery, Cardiopulmonary Transplantation, Cardiovascular Surgery

Cardiac surgery at New York Presbyterian Hospital

Overview of Dr. Naka

Dr. Yoshifumi Naka is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Osaka University Medical School and has been in practice 33 years. He is one of 59 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 143 doctors at New York-Presbyterian Hospital who specialize in Thoracic Surgery. He also speaks multiple languages, including Japanese. He has more than 100 publications and over 500 citings.

Office
177 Fort Washington Ave
# 7-435
New York, NY 10032
Book by Phone+1(229) 321-4292

Fax+1 646-426-0156

Education & Training

Osaka University Medical SchoolClass of 1984
Osaka UniversityBachelors, Pre-med, 1978 - 1968

Certifications & Licensure

NY State Medical License 1999 - 2026

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
Top Doctors: New York Metro Area Castle Connolly, 2006-2014
New York Magazine: Top Doctors Castle Connolly, 2005-2009, 2011-2014
Nominated for Socrates award Thoracic Surgery Residents Association (TSRA), 2011
Award for Achievement in Cardiovascular Science and Medicine American Heart Association, NY chapter, 2010
Finalist of the Cournand and Comroe Young Investigator Prize, 68th Annual Meeting of American Heart Association American Heart Association, 1995
First Prize, Residents Research Prize Competition College of Physicians and Surgeons of Columbia University, 1994-1995
Young Investigators Award Japanese Association for Thoracic Surgery, 1988
Join now to see all

Clinical Trials

Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure Start of enrollment: 2007 Sep 01
Terminated
Phase 2
Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS Start of enrollment: 2008 Jul 01
Terminated
Not Applicable
Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation Start of enrollment: 2009 Mar 01
Completed
Not Applicable
Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA) Start of enrollment: 2009 Jun 01
Terminated
Phase 2
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD Start of enrollment: 2009 Aug 01
Terminated
Phase 2
REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE Start of enrollment: 2015 Jul 01
Completed
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation Start of enrollment: 2012 Apr 01
Completed
Phase 2
The Epidemiology of Ventricular Assist Device-Related Infections Start of enrollment: 2006 Jan 01
Completed
The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices Start of enrollment: 2006 Jan 01
Terminated
An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery Start of enrollment: 2013 Jan 01
Completed
Not Applicable
A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) Start of enrollment: 2013 Oct 01
Completed
Not Applicable
MOMENTUM 3 IDE Clinical Study Protocol Start of enrollment: 2014 Sep 02
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Validation of the HeartMate 3 survival risk score in a large left ventricular assist device center.
Cathrine M Moeller, Gal Rubinstein, Daniel Oren, Andrea Fernandez Valledor, Dor Lotan
The Journal of Thoracic and Cardiovascular Surgery. 2025-02-01
Glucagon-Like Peptide-1 Receptor Agonists in Patients With Durable Left Ventricular Assist Devices.
Boaz Elad, Changhee Lee, Afsana Rahman, Wojciech Rzechorzek, Ersilia M DeFilippis
Artificial Organs. 2025-01-21
Outcomes After Heartmate 3 Left Ventricular Assist Device Implantation Using a 10 mm Outflow Graft.
Berhane Worku, Alice Vinogradsky, Aminat Ibrahim, Camilla Sofia Rossi, Charles Mack
ASAIO Journal. 2025-01-01

Journal Articles

Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019
Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?
Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support
Wasson LT, Yuzefpolskaya M, Wakabayashi M, Takayama H, Naka Y, Uriel N, Jorde UP, Demmer RT, Colombo PC, Heart Fail Rev., 1/1/2015
Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients
Jorde UP, Uriel N, Nahumi N, Bejar D, Gonzalez-Constello J, Thomas SS, Han J, Morrison KA, Jones S, Kodali S, Hahn RT, Shames S, Yuzefpolskaya M, Colombo P, Takayama H..., Circ Heart Fail., 1/1/2014
Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices
John R, Naka Y, Park SJ, Sai-Sudhakar C, Salerno C, Sundareswaran KS, Farrar DJ, Milano CA, J Thoratec Cardiovasc Surg, 1/1/2014
Myocardial infarction after left ventricular assist device implantation: clinical course, role of aortic root thrombus, and outcomes
Fried J, Han J, Naka Y, Jorde UP, Uriel N, J Heart Lung Transplant, 1/1/2014
Extended trans-septal and left atrial dome incision combined with Manouguian’s aortotomy for complex double valve surgery
Nishimura T, Ota T, Takayama H, Naka Y, Eur J Cardiothoracic Surg, 1/1/2014
Acute mechanical circulatory support o fulminant myocardiogenic shock
Mody KP, Takayama H, Landes E, Yuzefpolskaya M, Colombo PC, Naka Y, Jorde UP, Uriel N, J Cardiovasc Transl Res., 1/1/2014
Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement
Chung CJ, Wu C, Jones M, Kato TS, Dam TT, Givens R, Templeton DL, Maurer MC, Naka Y, Takayama H, Mancini DM, Schulze PC, J Card Fail, 1/1/2014
Acquired von Willebrand disease during CentriMag support is associated with high prevalence of bleeding during support and after transition to heart replacement therapy
Morrison KA, Jorde UP, Garan AR, Takayama H, Naka Y, Uriel N, ASAIO J, 1/1/2014
Results of the destination therapy post-FDA-approval study with a continuous flow left ventricular assist device: A prospective study using the INTEWMACS Registry
Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ; HeartMate II Clinica..., J Am Coll Cardiol, 1/1/2014
Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous flow left ventricular assist devices
Garan AR, Iyer V, Whang W, Mody KP, Yuzefpolskaya M, Colombo PC, Te-Frey R, Takayama H, Naka Y, Garan H, Jorge UP, Uriel N, ASAIO J, 1/1/2014
Post-transplant survival estimation using pre-operative albumin levels
Kato TS, Lippel M, Naka Y, Mancini DM, Schulze PC, J Heart Lung Transplant, 1/1/2014
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices
Ascheim DD, Gelijns AS, Goldstein D, Moye LA, Smedila N, Lee S, Klodell CT, Szady A, Parides MK, Jeffries NO, Skerrett D, Taylor DA, Rame JE, Milano C, Rogers JG, Lync..., Circulation, 1/1/2014
Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score
Thomas SS, Naumi N, Han J, Lippel M, Colombo P, Yuzefpolskaya M, Takayama H, Naka Y, Uriel N, Jorde P, J Heart Lung Transplant, 1/1/2014
Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: The DuraHeart Trial
Moazami N, Steffen RJ, Naka Y, Norde U, Bailey S, Murali S, Camacho MT, Zucker M, Marascalco PJ, Rao V, Feldman D; SUSTANI investigators, Ann Thorac Surg, 1/1/2014
Advanced heart failure in patients infected with human immunodeficiency virus: Is there equal access to care?
Uriel N, Numi N, Colombo PC, Yuzefpolskaya M, Restaino SW, Han J, Thomas SS, Garan AR, Takayama H, Mancini DM, Naka Y, Jorde UP, J Heart Lung Transplant, 1/1/2014
Bridge-to-decision therapy with a continuous flow external ventricular assist device in refractory cardiogenic shock of various etiologies
Takayama H, Soni L, Kalesan B, Truby LK, Ota T, Cedola S, Khapley Z, Uriel N, Colombo P, Mancini DM, Jorde UP, Naka Y, Circ Heart Fail., 1/1/2014
Neutrophil gelatinase- associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist d...
Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y, Templeton DL George I, Farr MA, Mancini DM, Christian Schulze P, J Heart Lung Transplant., 1/1/2014
Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous flow left ventricular assist devices
Fried J, Levin AP Mody KM, Garan AR, Yuzefpolskaya M, Takayama H, Diuguid DL, Naka Y, Jorde U, Uriel N, J Heart Lung Transplant., 1/1/2014
Ventricular assiste device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patien...
Khawja T, Chokshi A, Ji R, Kato TS, Xu K, Zizola C, Wu C, Forman DE, Ota T, Kennel P, Takayama H, Naka Y, George I, Mancini D, Schulze CP, J Cachexia Sarcopenia Muscle, 1/1/2014
Single center experience with a minimally invasive apicoaxillary external left ventricular assist device
Landes E, Naka Y, Takeda K, Takayama H, J Thorac Cardiovasc Surg., 1/1/2014
Long-term outcome of patients on continuous-flow left ventricular assist device support
Takeda K, Takayama H, Kalesan B, Uriel N, Colombo PC, Jorde UP, Naka Y, J Thorac Cardiovasc Surg., 1/1/2014
Subcostal to rib-cross incision for HeartMate Ii explantation: A case report
Nishimura T, Ota T, Takayama H, Naka Y, J Thorac Cardiovasc Surg., 1/1/2013
Clinical outcome of mechanical circulatory surpport for refractory cardiogenic shock in the current era
Takayama H, Truby L, Koekert M, Uriel N, Colombo P, Mancini DM, Jorde UP, Naka Y, J Heart Lung Transplant, 1/1/2013
Join now to see all

Books/Book Chapters

Ventricular assist devices in advanced-stage heart failure
Chapter: Chapter 6. Transplant versus VAD: Evolving and Future Perspectives.
Takayama H, Thomas S, Naka YEditors: Shunei Kyo.Springer2014
Surgical Treatment of Advanced Heart Failure
Morgan J and Naka YSpringer2013
Cardiothoracic Surgery Review
Chapter: Chapter 177. Redo Heart Transplantation (Columbia Experience).
Takayama H, Yang J, Naka YEditors: Franco KL, Thourani VH.Wolters Kluwer/Lippincott Williams&Wilkins2012
Cardiothoracic Surgery Review
Chapter: Cardiothoracic Surgery on Patients with Mechanical Circulatory Support Devices.
Takayama H, Yang J, Naka YEditors: Franco KL, Thourani VH.Wolters Kluwer/Lippincott Williams&Wilkins2012
Cardiac Surgery in the Adult
Chapter: Chapter 66. Long-term Mechanical Circulatory Support.
Page 1353 - 1372Takayama H, Worku B, Naka YEditors: Cohn LH.McGraw Hill MedicalEdition 4th,2012
Heart Transplantation
Chapter: HeartMate II.
Takayama H, Naka YEditors: Matsuda H.Springer, Japan, Tokyo, Japan2011
A Society of Cardiovascular Anesthesiologists Monograph. Postoperative Cardiac Care
Chapter: Postoperative Management of the patient with a Ventricular Assist Device. (Chapter 11)
Page 191 - 206Takayama H, Worku B, Naka YEditors: Sladen RN, Fanshawe M.Wolters Kluwer/Lippincott Williams&Wilkins2011
Cardiac Intensive Care
Chapter: Ventricular assist device therapy in advanced heart failure – State of the art.
Page 576 - 585Sayer G, Naka Y, Jorde UPEditors: Jeremias and Brown.Elsevier SaundersEdition 2nd,2010
Sabiston & Spencer Surgery of the Chest
Chapter: Ventricular assist devices.
Page 1507 - 1524Morgan JA, Oz MC , Naka YEditors: Sellke FW, del Nido PJ, Swanson SJ.Elsevier SaundersEdition 8th,2010
Mechanical Circulatory Support Therapy in Advanced Heart Failure
Deng M and Naka YImperial Press2007
Braunwald’s Heart Disease
Chapter: Assisted Circulation in the Treatment of Heart Failure.
Page 685 - 696Naka Y, Rose EAEditors: Zippes, Libby, Bonow, Mann.Elsevier Saunders, PhiladelphiaEdition 8th,2007
Mastery of Cardiothoracic Surgery
Chapter: Ventricular Assist.
Page 500 - 509Dang NC, Oz MC, Naka Y.Editors: Kaiser LR, Kron IL, Spray TL.Lippincott Williams & Wilkins, PhiladelphiaEdition 2nd,2006
Mechanical Circulatory Support. ISHLT Monograph Series.
Chapter: Positive Displacement Ventricular Assist Devices.
Page 53 - 76Hill JD, Farrar DJ, Naka Y, Chen JM, Portner PM, Loisance DEditors: Frazier OH, and Kirklin JK.Elsevier Saunders2006
Annals of the NY Acad Sci.: The Maillard Reaction: Chemistry at the Interface of Nutrition, Aging and Disease
Chapter: Receptor for Advanced Glycation Endproducts and its ligands: a journey from the complications of diabetes to its pathogenesis.
Page 553 - 561Kim W, Hudson BI, Moser B, Guo J, Rong LL, Lu Y, Qu W, Lalla E, Lerner S, Chen,Y, Yan SSD. D'Agati V, Naka Y, Ramasamy R, Herold K, Yan SF, Schmidt AMEditors: Baynes, J.W., Monnier, V.M., Ames, J.M., and Thorpe, S.R..New York, NY2005
Sabiston & Spencer Surgery of the Chest
Chapter: Left ventricular assist devices.
Page 1613 - 1630DiGiorgi PL, Kukuy EL, Naka Y, Oz MCEditors: Sellke FW, del Nido PJ, Swanson SJ.Elsevier SaundersEdition 7th,2005
Atherothrombosis and coronary artery disease
Chapter: The pathophysiology and biochemistry of myocardial ischemia, necrosis, and reperfusion.
Page 825 - 837Naka Y, Stern DM, Pinsky DJEditors: Fuster V, Topol EJ, Nabe EG.Lippincott Williams & Wilkins Publishers, Philadelphia2004
Surgical Management of Congestive Heart Failure
Chapter: Left ventricular assist devices.
Page 155 - 189DiGiorgi PL, Naka Y, Oz MCEditors: Fang JC, and Couper GS.Humana Press, Totowa2004
Braunwald’s Heart Disease
Chapter: Assisted Circulation in Heart Failure.
Page 625 - 639Naka Y, Chen CM, Rose EAEditors: Zippes, Libby, Bonow, Braunwald.Elsevier Saunders, PhiladelphiaEdition 7th,2004
Cardiac Transplantation
Chapter: Mechanical circulatory assistance as a bridge to transplantation.
Page 245 - 274Kohmoto T, Naka YEditors: Edwards NM, Chen JM, and Mazzeo PA.Humana Press2004
Myocardial Protection
Chapter: Myocardial protection during left ventricular assist device implantation.
Page 301 - 303Kherani AR, Oz MC, Naka YEditors: Salerno TA, and Ricci M.Blackwell Publishing, New York2004
Cardiac Surgery in the Adult
Chapter: Long-term mechanical circulatory support.
Page 1491 - 1505Kukuy EL, Oz MC, Naka YEditors: Cohn LH and Edmunds LH Jr..McGraw-Hill Medical Publishing Division, New YorkEdition 2nd,2004
Ventricular Assist Devices and the Artificial Heart
Chapter: Devices as destination therapy.
Page 67 - 73Kukuy EL, Oz MC, Rose EA, Naka YEditors: Samuels LE and Narula J.Cardiol Clinics2003
Atherosclerosis and coronary heart disease.
Chapter: The pathophysiology and biochemistry of myocardial ischemia, necrosis, and reperfusion.
Page 807 - 817Naka Y, Stern DM, Pinsky DJEditors: Fuster V, Ross R, Topol EJ.Lippincott Raven Publishers, Philadelphia1996
Join now to see all

Authored Content

Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020

Press Mentions

A Second Chance in Life: Bronx Woman Gets New Heart at NewYork-PresbyterianDecember 20th, 2024
NewYork-Presbyterian Expands Heart Transplant and Heart Failure ServicesNovember 1st, 2022
NewYork-Presbyterian Expands Heart Transplant and Heart Failure ServicesNovember 1st, 2022
Join now to see all